BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2017
View Archived Issues
EpiThany, Merck KGaA and Pfizer to evaluate avelumab in combination with EP-101 in breast cancer
Read More
Otic Pharma renamed Novus Therapeutics following merger with Tokai Pharmaceuticals
Read More
Novel anti-CD30 CAR T-cell therapy enters clinical study for T-cell malignancies
Read More
Meissa Vaccines receives NIH grant to support development of rhinovirus vaccine
Read More
FDA expands BTD for Rhythm Pharmaceuticals' setmelanotide
Read More
Dosing begins in Abide Therapeutics' fMRI study of ABX-1431
Read More
Taiwan FDA approves quadrivalent flu vaccine from Adimmune
Read More
Synthetic Biologics' SYN-004 earns FDA breakthrough therapy designation
Read More
Corium's Corplex Donepezil demonstrates bioequivalence in pilot study
Read More
Lexicon Pharmaceuticals reports additional data from phase III inTandem1 study
Read More
Lundbeck updates pipeline progress of first quarter 2017
Read More
Newron receives milestone payments linked to FDA approval of Xadago
Read More
Mitsubishi Tanabe profiles pipeline progress of fourth quarter of fiscal 2016
Read More
Asterias reports promising MRI data from SCiStar trial of AST-OPC1 in spinal cord injury
Read More
Etripamil demonstrates statistically significant efficacy in NODE-1 trial in PSVT
Read More
Eisai offers overview of fourth quarter of fiscal 2016
Read More
PACIFIC trial of durvalumab in stage III NSCLC meets PFS primary endpoint
Read More
Beijing Konruns Pharmaceutical Technology identifies novel PDE4 inhibitors
Read More
INC Research and inVentiv Health set to merge
Read More
Norgine to acquire all shares of Merus Labs International
Read More
Jiangsu Nhwa, Wuhan Jiayu patent dopamine and serotonin receptor ligands
Read More
NG34scFvPD-1 preclinical data show promise for glioblastoma treatment
Read More
Mayo Clinic, Arizona State describe novel anticancer compound targeting QSOX1
Read More
rAd.DCN.GM induces antitumor effect in a murine colorectal cancer model
Read More
Takeda reviews key events of fourth quarter of fiscal 2016
Read More
